OMDA PE Ratio & Valuation,Is OMDA Overvalued

OMDA Relative Valuation

OMDA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OMDA is overvalued; if below, it's undervalued.

Historical Valuation

Omada Health Inc (OMDA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -139.19. The fair price of Omada Health Inc (OMDA) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：14.59

Fair

-43.83

541.67

EV/EBITDA

Omada Health Inc. (OMDA) has a current EV/EBITDA of 541.67. The 5-year average EV/EBITDA is 244.66. The thresholds are as follows: Strongly Undervalued below -863.32, Undervalued between -863.32 and -309.33, Fairly Valued between 798.65 and -309.33, Overvalued between 798.65 and 1352.64, and Strongly Overvalued above 1352.64. The current Forward EV/EBITDA of 541.67 falls within the Historic Trend Line -Fairly Valued range.

-34.42

EV/EBIT

Omada Health Inc. (OMDA) has a current EV/EBIT of -34.42. The 5-year average EV/EBIT is -50.41. The thresholds are as follows: Strongly Undervalued below -78.71, Undervalued between -78.71 and -64.56, Fairly Valued between -36.26 and -64.56, Overvalued between -36.26 and -22.11, and Strongly Overvalued above -22.11. The current Forward EV/EBIT of -34.42 falls within the Overvalued range.

2.85

Omada Health Inc. (OMDA) has a current PS of 2.85. The 5-year average PS is 4.18. The thresholds are as follows: Strongly Undervalued below 2.13, Undervalued between 2.13 and 3.15, Fairly Valued between 5.20 and 3.15, Overvalued between 5.20 and 6.23, and Strongly Overvalued above 6.23. The current Forward PS of 2.85 falls within the Undervalued range.

170.98

P/OCF

Omada Health Inc. (OMDA) has a current P/OCF of 170.98. The 5-year average P/OCF is 76.58. The thresholds are as follows: Strongly Undervalued below -221.99, Undervalued between -221.99 and -72.70, Fairly Valued between 225.86 and -72.70, Overvalued between 225.86 and 375.14, and Strongly Overvalued above 375.14. The current Forward P/OCF of 170.98 falls within the Historic Trend Line -Fairly Valued range.

334.29

P/FCF

Omada Health Inc. (OMDA) has a current P/FCF of 334.29. The 5-year average P/FCF is 177.90. The thresholds are as follows: Strongly Undervalued below -357.69, Undervalued between -357.69 and -89.89, Fairly Valued between 445.70 and -89.89, Overvalued between 445.70 and 713.50, and Strongly Overvalued above 713.50. The current Forward P/FCF of 334.29 falls within the Historic Trend Line -Fairly Valued range.

Omada Health Inc (OMDA) has a current Price-to-Book (P/B) ratio of 3.89. Compared to its 3-year average P/B ratio of 4.77 , the current P/B ratio is approximately -18.43% higher. Relative to its 5-year average P/B ratio of 4.77, the current P/B ratio is about -18.43% higher. Omada Health Inc (OMDA) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -1.53%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -1.53% , the current FCF yield is about -100.00% lower.

3.89

P/B

Median3y

4.77

Median5y

4.77

-1.29

FCF Yield

Median3y

-1.53

Median5y

-1.53

Competitors Valuation Multiple

The average P/S ratio for OMDA's competitors is , providing a benchmark for relative valuation. Omada Health Inc Corp (OMDA) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 49.47%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of OMDA decreased by 20.16% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 45.52M to 68.03M.

The secondary factor is the P/E Change, contributed 7.33%to the performance.

Overall, the performance of OMDA in the past 1 year is driven by Revenue Growth. Which is more sustainable.

49.47%

45.52M → 68.03M

Revenue Growth

-76.96%

-20.27 → -4.67

Margin Expansion

7.33%

-12.50 → -13.42

P/E Change

-20.16%

18.30 → 14.61

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Omada Health Inc (OMDA) currently overvalued or undervalued?

What is Omada Health Inc (OMDA) fair value?

OMDA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Omada Health Inc (OMDA) is between NaN to NaN according to relative valuation methord.

How does OMDA's valuation metrics compare to the industry average?

What is the current P/B ratio for Omada Health Inc (OMDA) as of Dec 17 2025?

As of Dec 17 2025, Omada Health Inc (OMDA) has a P/B ratio of 3.89. This indicates that the market values OMDA at 3.89 times its book value.

What is the current FCF Yield for Omada Health Inc (OMDA) as of Dec 17 2025?

As of Dec 17 2025, Omada Health Inc (OMDA) has a FCF Yield of 0.00%. This means that for every dollar of Omada Health Inc’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Omada Health Inc (OMDA) as of Dec 17 2025?

As of Dec 17 2025, Omada Health Inc (OMDA) has a Forward P/E ratio of -43.80. This means the market is willing to pay $-43.80 for every dollar of Omada Health Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Omada Health Inc (OMDA) as of Dec 17 2025?

As of Dec 17 2025, Omada Health Inc (OMDA) has a Forward P/S ratio of 0.00. This means the market is valuing OMDA at $0.00 for every dollar of expected revenue over the next 12 months.

OMDA Valuation